Sensorion Reports Full-Year 2023 Financial Results and Business Update
Pharmaceutical Daily,
Milestone achieved for SENS-501 gene therapy program with Clinical Trial Application approval in Europe (France as first country…
Milestone achieved for SENS-501 gene therapy program with Clinical Trial Application approval in Europe (France as first country…
Milestone achieved for SENS-501 gene therapy program with Clinical Trial Application approval in Europe (France as first country…
MONTPELLIER, France Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) société de biotechnologie pionnière au…
Milestone achieved for SENS-501 gene therapy program with Clinical Trial Application approval in Europe (France as first country…